Search

Your search keyword '"Schmitz, T."' showing total 1,066 results
Start Over Author "Schmitz, T."
1,066 results on '"Schmitz, T."'

102. Prévention des complications de la prématurité par l’administration anténatale de corticoïdes

Author

Schmitz T

Subjects
Gynecology, Pregnancy, medicine.medical_specialty, 030219 obstetrics & reproductive medicine, business.industry, Adrenal cortex hormones, Obstetrics and Gynecology, General Medicine, medicine.disease, Infant newborn, 03 medical and health sciences, 0302 clinical medicine, Intraventricular hemorrhage, Reproductive Medicine, Premature birth, 030225 pediatrics, medicine, Betamethasone, business, medicine.drug
Abstract

Journal de Gynecologie Obstetrique et Biologie de la Reproduction - Vol. 45 - N° 10 - p. 1399-1417

Published
2016

104. Dual antiplatelet therapy duration after coronary stenting in clinical practice: results of an EAPCI survey

Author

Valgimigli, M, Costa, F, Byrne, R, Haude, M, Baumbach, A, Windecker, S, Aaroe, J, Aasa, M, Abdel-Salam, Am, Alaarag, Af, Accardi, R, Adel, A, Alcazar De La Torre, E, Alejos, R, Alfonso Jimenez, V, Alhashimi, Hmm, Aljeboury, A, Almeida De Sousa, J, Almusawi, A, Alshaikha, M, Altaf, S, Altahmody, Kea, Alvarez Contreras, Lr, Amarasena, N, Amoroso, G, Anderson, R, Ando, G, Andrade, J, Andreou, Ay, Angulo, J, Antonio, T, Aprigliano, G, Aquilina, M, Arafa, Seo, Aramberry, L, Arampatzis, Ca, Araujo, Jj, Asher, E, Ates, I, Athanasias, D, Auer, J, Auffret, V, Ayala, Fj, Baba, C, Baglioni, P, Bagur, R, Balam-Ortiz, E, Balducelli, M, Bam Pas, G, Barbash, Im, Barbosa, Ahp, Barbosa, R, Barnay, P, Barroso, L, Basti, A, Bax, M, Bayet, G, Beijk, Ma, Beltran, R, Berenguer Jofresa, A, Berroth, R, Berti, S, Berumen Dominguez, Le, Bhasin, A, Bhaya, M, Bianco, M, Biasco, L, Bikicki, M, Bonarjee, Vvs, Bonechi, F, Borges Santos, M, Boshev, M, Bouferrouk, A, Bounartzidi, M, Bousoula, E, Brie, D, Brtko, M, Brugaletta, S, Brull, Dj, Buchter, B, Buendia, R, Burzotta, F, Butz, T, Buzzetti, F, Bychowiec, B, Cadeddu, M, Campanile, A, Carneiro, Jg, Carrilho-Ferreira, P, Carrillo Guevara, Je, Carter, Aj, Casal-Heredia, H, Castiglioni, B, Castro Fabiano, L, Cavalcante Silva, R, Cavalcanti De Oliveira, D, Cavalcanti, Rc, Cavazza, C, Centemero, Mp, Chabane, Hk, Chamie, D, Chatzis, D, Chaves, Aj, Cheng, S, Chinchilla, H, Ciabatti, N, Cirillo, P, Citaku, H, Claeys, Mj, Clifford, C, Coceani, M, Coggiola, J, Cohen, Dj, Conway, Dsg, Cornelis, K, Coroleu, Sf, Corral, Jm, Cortese, B, Coskun, U, Costa, Ra, Coste, P, Coufal, Z, Cox, S, Cozma, A, Crean, P, Crenshaw, Mh, Cristian, U, Cruz-Alvarado, Je, Cuculi, F, Cuenza, L, Cyrne Carvalho, H, D'Ascenzo, F, D'Urbano, M, Damonte, A, Dan Florin, F, Dana, A, Dangoisse, V, De Backer, O, De Cock, D, De Vita, M, Debski, A, Delgado, A, Devadathan, S, Dhamrait, S, Di Lorenzo, E, Di Serafino, D, Diego-Nieto, A, Dievart, F, Diez, Jl, Dimitriadis, K, Dina, C, Doerner, O, Donahue, M, Donis, J, Drieghe, B, Drissi, Mf, Du Fretay, H, Dziewierz, A, Echavarria-Pinto, M, Echeverria Romero, Rg, Economou, F, Eftychiou, C, Egdell, R, El Hosieny, A, El Meguid, K, Elabbassi, W, Elesgerli, S, Elghetany, H, Elizondo, Jc, Elkahlout, A, Elrowiny, R, Elserafy, As, Emam, A, Emara, A, Emmanouil, P, Ercilla, J, Erglis, A, Eslam Taha, E, Esmaeil, S, Esposito, G, Ettori, F, Eugenio, N, Everaert, B, Ezquerra Aguilar, W, Falu, R, Farag, E, Farjalla, J, Feldman, L, Feldman, M, Felice, H, Fernandez-Nofrerias, E, Fernandez-Rodriguez, D, Ferranti, F, Ferreira, Q, Ferrone, M, Fleischmann, C, Flessas, D, Formigli, D, Fozilov, H, Fraccaro, C, Freitas, Jo, Fresco, C, Fridrich, V, Furmaniuk, J, Gagnor, A, Galasso, G, Galeazzi, Gl, Galli, S, Galvez Villacorta, V, Gandolfo, C, Garcia, E, Garcia-Blas, S, Garducci, S, Garg, S, Garro, N, Gatto, L, Georgiou, Mg, Ghanem, I, Ghose, T, Giacchi, G, Giang, Pt, Giesler, T, Giovino, M, Girardi, P, Girasis, C, Giunio, L, Giustino, G, Glatthor, C, Glogar, Hd, Golledge, P, Gomez Moreno, J, Gomez Recio, M, Gommeaux, A, Grantalis, G, Greco, F, Grundeken, Mj, Grunert, S, Gudmundsdottir, I, Guenoun, M, Guerios, E, Gupta, R, Gupta, S, Gutierrez, C, Hafeez, I, Halvorsen, S, Hamed Hussein, Ga, Hammoudeh, A, Hansen, Pr, Harb, S, Hawas, Jm, Hayrapetyan, H, Heintzen, Mp, Hengstenberg, C, Herity, N, Hernandez, F, Heyse, A, Hicham, D, Hildick-Smith, D, Hill, J, Hillani, A, Hiltrop, N, Hiramori, A, Hobson, Ar, Homan, Dj, Hooda, A, Ielasi, A, Ierna, S, Iftikhar, Ak, Ilic, I, Imai, Y, Imperadore, F, Indolfi, C, Iorga, V, Ipek, E, Ito, S, Jacksch, R, Jae-Sik, J, James, S, Jamshidi, P, Jerbi, J, Jimenez Quevedo, P, Jimenez-Navarro, M, Jimenez-Santos, M, Jin, Qh, Joksas, V, Jovic, D, Junejo, S, Kallel, R, Kamal, A, Kamiya, H, Kannan, D, Kantaria, M, Kapetanopoulos, A, Kara Ali, B, Karjalainen, Pp, Karthikeyan, Vj, Kato, R, Katsikis, A, Kefer, J, Keta, D, Ketteler, T, Khan, M, Kharlamov, A, Kinani, A, Kinani, T, Kinnaird, T, Kislo, A, Kiviniemi, T, Kleiban, A, Kluck, B, Kocayigit, I, Kokis, A, Komiyama, N, Konstantinos, L, Kordalis, A, Kozak, M, Krecki, R, Kristensen, Sd, Krizanic, F, Krsticevic, L, Kuex, H, Kukreja, N, Kulic, M, Kulikovskikh, Yv, Kulkarni, P, Kumar, N, Kumar Soni, A, Kuzmenko, E, L'Allier, Pl, Langner, O, Lapin, O, Lauer, B, Leclercq, F, Leibundgut, G, Leon Aliz, E, Leon, C, Leon, K, Leoncini, M, Leone, Am, Leroux, L, Lesiak, M, Letilovic, T, Lev, E, Linares Vicente, Ja, Lindsay, S, Loh, Ph, Loncar, G, Loo, B, Lopez, Mb, Lopez-Cuellar, J, Lozano, I, Luigia, P, Lunde, K, Lyczywek, M, Macdougall, D, Mafrici, A, Magni, V, Magro, M, Mainar, V, Makarovic, Z, Malik, N, Maly, M, Mansour, S, Marenco, Re, Maresta, A, Marinho, Ge, Marino, Rl, Marinucci, L, Martins, Hc, Martins, J, Mashayekhi, K, Masood, A, Maurer, E, Mavrogianni, Ad, Mazurek, T, Medina, A, Mehilli, J, Mellwig, Kp, Mendez, M, Mendiz, Oa, Meneses, A, Mercado, La, Mereuta, A, Mezzapelle, G, Milanovic, N, Mohamed, Sm, Mohanad, A, Mohanty, A, Moorthy, N, Morales, Fj, More, R, Moreno Samos, Jc, Moreno-Martinez, Fl, Moscato, F, Mossmann, M, Mrevlje, B, Muller-Eichelberg, A, Musumeci, G, Nadir Khan, M, Najim, S, Nakamura, S, Nakao, F, Naveri, H, Negus, B, Nerla, R, Nguyen, Ht, Niess, Gs, Nikas, Dn, Niroomand, F, Niva, J, Nogueira, Jw, Nombela-Franco, L, Notrica, M, Nouri, B, Nugue, O, Nunes, Gl, Ober, M, Ochoa, J, J. H., O, Ojeda, S, Oktay Tureli, H, Olowe, Y, Oluseun, A, Opolski, G, Ornelas, Ce, Otasevic, P, Ozturk, A, Padilla, F, Pagny, Jy, Paolantonio, D, Papaioannou, Gi, Parodi, G, Patil, Sn, Pavei, A, Pavia, A, Pavlidis, A, Pell, A, Percoco, Gf, Pernasetti, Lv, Pescoller, F, Petropoulakis, P, Piatti, L, Picardi, E, Pieroni, Dm, Pina, J, Pinheiro, Lf, Pinto, Fj, Pipa, Jl, Piroth, Z, Pisano, F, Podbregar, M, Polak, G, Polimeni, A, Postadzhiyan, A, Postu, M, Poulimenos, Le, Pow Chon Long, F, Poyet, R, Pradhan, A, Predescu, Lm, Prida, Xe, Saad, A, Prog, R, Pulikal, Dga, Qiangzhong, Pi, Radu, Md, Rajendran, D, Ram Anil Raj, Mr, Ramazzotti, V, Rapacciuolo, A, Ratib, K, Raungaard, B, Raviola, E, Reppas, E, Reyes, Ja, Rezek, M, Riess, Gj, Rifaie, O, Rigattieri, S, Rissanen, T, Ristic, Ad, Rittger, H, Roberts, J, Rodriguez Saavedra, A, Roik, M, Roshan Rao, K, Routledge, H, Rubboli, A, Rudolph, T, Rudzitis, A, Ruiters, A, Ruiz Ros, Ja, Ruiz-Garcia, J, Ruiz-Nodar, Jm, Sabate, M, Sabnis, G, Sabouret, P, Sacra, C, Saghatelyan, M, Sahin, M, Said, S, Salachas, Aj, Salas Llamas, Jp, Salih, A, Sanchez, Od, Sanchez-Gila, J, Sanchez-Perez, I, Santarelli, A, Sardovski, Sarenac, D, Sarma, J, Sarno, G, Savonitto, S, Sayied Abdullah, A, Schafer, A, Scherillo, M, Schneider, H, Schuhlen, H, Sciahbasi, A, Seca, L, Sedlon, P, Semenka, J, Serra, La, Sesana, M, Sethi, A, Sgueglia, Ga, Shaheen, S, Shahri, H, Sheiban, I, Shyu, Kg, Silva, Cef, Sionis, D, Siqueira, Da, Siqueira, Mj, Smits, P, Sobhy, M, Sokolov, M, Soliman, S, Somani, An, Sridhar, G, Stakos, D, Stasek, J, Stefanini, G, Steigen, Tk, Stewart, Stipal, R, Stochino, Ml, Stoel, Mg, Subla, Rm, Suliman, A, Summaria, F, Stoyanov, N, Syed, Aa, Tanaka, Y, Tashani, A, Tauzin, S, Tawade, N, Tawfik, M, Tayeh, O, Terzic, I, Testa, L, Thevan, B, Thiam, M, Tiecco, F, Tierala, I, Tilea, I, Tilsted, Hh, Tomasik, Ar, Tonev, I, Torres Bosco, A, Tousek, P, Townend, J, Tran Ngoc, T, Triantafyllou, K, Tsigkas, G, Tsioufis, C, Turri, M, Tyligadis, G, Ugo, F, Ultramari, Ft, Urban, P, Uren, N, Uretsky, Bf, Uribe, Ce, Usman, B, Valadez Molina, F, Van Houwelingen, Kg, Vandormael, M, Varvarovsky, I, Vassilis, V, Velasquez, D, Verdoia, M, Vermeersch, P, Vidal-Perez, R, Vinesh, J, Violini, R, Vista, Jh, Vogt, F, Vogt, M, Vokac, D, Vom Dahl, J, Vranckx, P, Wahab, A, Wang, R, Wang, Td, Wani, S, Weisz, Sh, Werner, Gs, Wilkinson, Jr, Wolf, A, Youssef, A, Yumoto, K, Zaderenko, N, Zaghloul Darwish, Am, Zahn, R, Zaro, T, Zavalloni, D, Zbinden, R, Zekanovic, D, Zhang, B, Zhang, C, Zhang, Yj, Zhonghan, N, Zingarelli, A, Zueco, J, Zuhairy, H, Abbate, A, Abdel Hamid, M, Abdelmegid, Maf, Acuna-Valerio, J, Adriaenssens, T, Agostoni, P, Aikot, H, Alameda, M, Alcaraz, H, Almendro-Delia, M, Altug Cakmak, H, Amir, A, Arjomand, A, Assomull, R, Atalar, E, Avramides, D, Aytek Simsek, M, Aznaouridis, K, Azpeitia, Y, Barnabas, C, Barsness, Gw, Bartorelli, Al, Basoglu, A, Benezet, J, Benincasa, S, Berland, J, Berrocal, Dh, Bett, N, Boskovic, S, Brandao, V, Caporale, R, Caprotta, F, Carrabba, N, Cazaux, P, Cheniti, G, Chinchilla Calix, H, Chung, Wy, Cicco, Na, Cieza, T, Clapp, B, Commeau, P, Cuellar, C, De Benedictis, M, De La Torre Hernandez, Jm, De Vroey, F, Degertekin, M, Eberli, Fr, Eggebrecht, H, Ekicibasi, E, Elmaraghi, M, Elod, P, Ergene, Ao, Fadlalla, Vf, Farah, Ma, Fernandez Vina, R, Ferro, A, Fischer, D, Flore, V, Foley, Dp, Gafoor, S, Gallo, S, Gaspardone, A, Gavrilescu, D, Gentiletti, A, Gilard, M, Giovannelli, F, Gonzalez Pacheco, I, Gonzalo, N, Grajek, S, Gurgel De Medeiros, Jp, Haine, S, Hakim, D, Hakim Vista, Jj, Hallani, H, Hamid, M, Helft, G, Heppell, Rm, Hernandez-Enriquez, M, Hlinomaz, O, Ho Choo, E, Huqi, A, Hurtado, Eo, Iakovou, I, Iosseliani, D, Janssens, L, Jean, M, Jensen, Jk, Jesudason, P, Jimenez Diaz, Va, Karchevsky, D, Karpovskii, A, Katsimagklis, G, Kereiakes, D, Kersanova, Nc, Kesavan, S, Khaled, H, Khalil, Sa, Kiatchoosakun, S, Kim, Ks, Kirma, C, Koltowski, L, Konteva, M, Kozinski, L, Kuehn, Cr, Kumar, S, Kyriakakis, Cg, Laanmets, P, Labrunie, A, Ladwiniec, A, Lai, G, Laine, M, Latib, A, Lattuca, B, Lazarevic, Am, Lee, Ks, Legrand, V, Leiva, G, Lester, N, Levchyshyna, O, Livia, G, Londero, Hf, Luha, O, Lupi, A, Lupkovics, G, Maaliki, S, Maeng, M, Mahr, Nc, Mantyla, P, Mariano, E, Marsit, N, Mcdonough, Tj, Medda, M, Mejia Viana, S, Merigo Azpir, Ca, Mitreski, S, Moreno, R, Moreu, J, Muehler, M, Muir, D, Munoz Molina, R, Musilli, N, Myc, J, Nadra, I, Nagy, Cd, Narayanan, A, Neugebauer, P, Nguyen, M, Nick, H, Nicolino, A, Obradovic, Sd, Paizis, I, Panagiotis, P, Park, Sd, Park, Sj, Pasquetto, G, Patel, D, Paunovic, D, Pedon, L, Pereira Machado, F, Pershukov, H, Petrou, E, Pinton, Fa, Preti, G, Puri, R, Pyxaras, Sa, Quintanilla, J, Rhouati, A, Ribeiro De Oliveira, I, Rivetti, L, Rodriguez, Ae, Rotevatn, S, Rubartelli, P, Sachdeva, R, Sanchez-Perez, H, Sangiorgi, G, Santoro, Gm, Saporito, F, Scappaticci, M, Schmermund, A, Schmidt, Je, Schmitz, T, Schneider, Ti, Schuchlenz, H, Sepulveda Varela, P, Shaw, E, Silva Marques, J, Skalidis, E, Slhessarenko, J, Spaulding, C, Stankovic, G, Suwannasom, P, Synetos, A, Szuster, E, Taha, S, Tavano, D, Tebet, M, Thury, A, Toutouzas, K, Triantafyllis, As, Tsikaderis, D, Tumscitz, C, Tzanogiorgis, I, Udovichenko, A, Ulrike, N, Unikas, R, Valerio, Mg, Van Mieghem, C, Vandendriessche, T, Vavlukis, M, Vigna, C, Vilar, Jv, Vizzari, G, Voudris, V, Wafa, S, Wagner, Dr, Wichter, T, Wiedemann, S, Williams, Pd, Woody, W, Yding, A, Zachow, G, Webster, M, Valgimigli, M., Costa, F., Byrne, R., Haude, M., Baumbach, A., Windecker, S., Aaroe, J., Aasa, M., Abdel-Salam, A. M., Alaarag, A. F., Accardi, R., Adel, A., Alcazar De La Torre, E., Alejos, R., Alfonso Jimenez, V., Alhashimi, H. M. M., Aljeboury, A., Almeida De Sousa, J., Almusawi, A., Alshaikha, M., Altaf, S., Altahmody, K. E. A., Alvarez Contreras, L. R., Amarasena, N., Amoroso, G., Anderson, R., Ando, G., Andrade, J., Andreou, A. Y., Angulo, J., Antonio, T., Aprigliano, G., Aquilina, M., Arafa, S. E. O., Aramberry, L., Arampatzis, C. A., Araujo, J. J., Asher, E., Ates, I., Athanasias, D., Auer, J., Auffret, V., Ayala, F. J., Baba, C., Baglioni, P., Bagur, R., Balam-Ortiz, E., Balducelli, M., Bam Pas, G., Barbash, I. M., Barbosa, A. H. P., Barbosa, R., Barnay, P., Barroso, L., Basti, A., Bax, M., Bayet, G., Beijk, M. A., Beltran, R., Berenguer Jofresa, A., Berroth, R., Berti, S., Berumen Dominguez, L. E., Bhasin, A., Bhaya, M., Bianco, M., Biasco, L., Bikicki, M., Bonarjee, V. V. S., Bonechi, F., Borges Santos, M., Boshev, M., Bouferrouk, A., Bounartzidi, M., Bousoula, E., Brie, D., Brtko, M., Brugaletta, S., Brull, D. J., Buchter, B., Buendia, R., Burzotta, F., Butz, T., Buzzetti, F., Bychowiec, B., Cadeddu, M., Campanile, A., Carneiro, J. G., Carrilho-Ferreira, P., Carrillo Guevara, J. E., Carter, A. J., Casal-Heredia, H., Castiglioni, B., Castro Fabiano, L., Cavalcante Silva, R., Cavalcanti De Oliveira, D., Cavalcanti, R. C., Cavazza, C., Centemero, M. P., Chabane, H. K., Chamie, D., Chatzis, D., Chaves, A. J., Cheng, S., Chinchilla, H., Ciabatti, N., Cirillo, P., Citaku, H., Claeys, M. J., Clifford, C., Coceani, M., Coggiola, J., Cohen, D. J., Conway, D. S. G., Cornelis, K., Coroleu, S. F., Corral, J. M., Cortese, B., Coskun, U., Costa, R. A., Coste, P., Coufal, Z., Cox, S., Cozma, A., Crean, P., Crenshaw, M. H., Cristian, U., Cruz-Alvarado, J. E., Cuculi, F., Cuenza, L., Cyrne Carvalho, H., D'Ascenzo, F., D'Urbano, M., Damonte, A., Dan Florin, F., Dana, A., Dangoisse, V., De Backer, O., De Cock, D., De Vita, M., Debski, A., Delgado, A., Devadathan, S., Dhamrait, S., Di Lorenzo, E., Di Serafino, D., Diego-Nieto, A., Dievart, F., Diez, J. L., Dimitriadis, K., Dina, C., Doerner, O., Donahue, M., Donis, J., Drieghe, B., Drissi, M. F., Du Fretay, H., Dziewierz, A., Echavarria-Pinto, M., Echeverria Romero, R. G., Economou, F., Eftychiou, C., Egdell, R., El Hosieny, A., El Meguid, K., Elabbassi, W., Elesgerli, S., Elghetany, H., Elizondo, J. C., Elkahlout, A., Elrowiny, R., Elserafy, A. S., Emam, A., Emara, A., Emmanouil, P., Ercilla, J., Erglis, A., Eslam Taha, E., Esmaeil, S., Esposito, G., Ettori, F., Eugenio, N., Everaert, B., Ezquerra Aguilar, W., Falu, R., Farag, E., Farjalla, J., Feldman, L., Feldman, M., Felice, H., Fernandez-Nofrerias, E., Fernandez-Rodriguez, D., Ferranti, F., Ferreira, Q., Ferrone, M., Fleischmann, C., Flessas, D., Formigli, D., Fozilov, H., Fraccaro, C., Freitas, J. O., Fresco, C., Fridrich, V., Furmaniuk, J., Gagnor, A., Galasso, G., Galeazzi, G. L., Galli, S., Galvez Villacorta, V., Gandolfo, C., Garcia, E., Garcia-Blas, S., Garducci, S., Garg, S., Garro, N., Gatto, L., Georgiou, M. G., Ghanem, I., Ghose, T., Giacchi, G., Giang, P. T., Giesler, T., Giovino, M., Girardi, P., Girasis, C., Giunio, L., Giustino, G., Glatthor, C., Glogar, H. D., Golledge, P., Gomez Moreno, J., Gomez Recio, M., Gommeaux, A., Grantalis, G., Greco, F., Grundeken, M. J., Grunert, S., Gudmundsdottir, I., Guenoun, M., Guerios, E., Gupta, R., Gupta, S., Gutierrez, C., Hafeez, I., Halvorsen, S., Hamed Hussein, G. A., Hammoudeh, A., Hansen, P. R., Harb, S., Hawas, J. M., Hayrapetyan, H., Heintzen, M. P., Hengstenberg, C., Herity, N., Hernandez, F., Heyse, A., Hicham, D., Hildick-Smith, D., Hill, J., Hillani, A., Hiltrop, N., Hiramori, A., Hobson, A. R., Homan, D. J., Hooda, A., Ielasi, A., Ierna, S., Iftikhar, A. K., Ilic, I., Imai, Y., Imperadore, F., Indolfi, C., Iorga, V., Ipek, E., Ito, S., Jacksch, R., Jae-Sik, J., James, S., Jamshidi, P., Jerbi, J., Jimenez Quevedo, P., Jimenez-Navarro, M., Jimenez-Santos, M., Jin, Q. H., Joksas, V., Jovic, D., Junejo, S., Kallel, R., Kamal, A., Kamiya, H., Kannan, D., Kantaria, M., Kapetanopoulos, A., Kara Ali, B., Karjalainen, P. P., Karthikeyan, V. J., Kato, R., Katsikis, A., Kefer, J., Keta, D., Ketteler, T., Khan, M., Kharlamov, A., Kinani, A., Kinani, T., Kinnaird, T., Kislo, A., Kiviniemi, T., Kleiban, A., Kluck, B., Kocayigit, I., Kokis, A., Komiyama, N., Konstantinos, L., Kordalis, A., Kozak, M., Krecki, R., Kristensen, S. D., Krizanic, F., Krsticevic, L., Kuex, H., Kukreja, N., Kulic, M., Kulikovskikh, Y. V., Kulkarni, P., Kumar, N., Kumar Soni, A., Kuzmenko, E., L'Allier, P. L., Langner, O., Lapin, O., Lauer, B., Leclercq, F., Leibundgut, G., Leon Aliz, E., Leon, C., Leon, K., Leoncini, M., Leone, A. M., Leroux, L., Lesiak, M., Letilovic, T., Lev, E., Linares Vicente, J. A., Lindsay, S., Loh, P. H., Loncar, G., Loo, B., Lopez, M. B., Lopez-Cuellar, J., Lozano, I., Luigia, P., Lunde, K., Lyczywek, M., Macdougall, D., Mafrici, A., Magni, V., Magro, M., Mainar, V., Makarovic, Z., Malik, N., Maly, M., Mansour, S., Marenco, R. E., Maresta, A., Marinho, G. E., Marino, R. L., Marinucci, L., Martins, H. C., Martins, J., Mashayekhi, K., Masood, A., Maurer, E., Mavrogianni, A. D., Mazurek, T., Medina, A., Mehilli, J., Mellwig, K. P., Mendez, M., Mendiz, O. A., Meneses, A., Mercado, L. A., Mereuta, A., Mezzapelle, G., Milanovic, N., Mohamed, S. M., Mohanad, A., Mohanty, A., Moorthy, N., Morales, F. J., More, R., Moreno Samos, J. C., Moreno-Martinez, F. L., Moscato, F., Mossmann, M., Mrevlje, B., Muller-Eichelberg, A., Musumeci, G., Nadir Khan, M., Najim, S., Nakamura, S., Nakao, F., Naveri, H., Negus, B., Nerla, R., Nguyen, H. T., Niess, G. S., Nikas, D. N., Niroomand, F., Niva, J., Nogueira, J. W., Nombela-Franco, L., Notrica, M., Nouri, B., Nugue, O., Nunes, G. L., Ober, M., Ochoa, J., Oh, J. H., Ojeda, S., Oktay Tureli, H., Olowe, Y., Oluseun, A., Opolski, G., Ornelas, C. E., Otasevic, P., Ozturk, A., Padilla, F., Pagny, J. Y., Paolantonio, D., Papaioannou, G. I., Parodi, G., Patil, S. N., Pavei, A., Pavia, A., Pavlidis, A., Pell, A., Percoco, G. F., Pernasetti, L. V., Pescoller, F., Petropoulakis, P., Piatti, L., Picardi, E., Pieroni, D. M., Pina, J., Pinheiro, L. F., Pinto, F. J., Pipa, J. L., Piroth, Z., Pisano, F., Podbregar, M., Polak, G., Polimeni, A., Postadzhiyan, A., Postu, M., Poulimenos, L. E., Pow Chon Long, F., Poyet, R., Pradhan, A., Predescu, L. M., Prida, X. E., Saad, A., Prog, R., Pulikal, D. G. A., Qiangzhong, P. I., Radu, M. D., Rajendran, D., Ram Anil Raj, M. R., Ramazzotti, V., Rapacciuolo, A., Ratib, K., Raungaard, B., Raviola, E., Reppas, E., Reyes, J. A., Rezek, M., Riess, G. J., Rifaie, O., Rigattieri, S., Rissanen, T., Ristic, A. D., Rittger, H., Roberts, J., Rodriguez Saavedra, A., Roik, M., Roshan Rao, K., Routledge, H., Rubboli, A., Rudolph, T., Rudzitis, A., Ruiters, A., Ruiz Ros, J. A., Ruiz-Garcia, J., Ruiz-Nodar, J. M., Sabate, M., Sabnis, G., Sabouret, P., Sacra, C., Saghatelyan, M., Sahin, M., Said, S., Salachas, A. J., Salas Llamas, J. P., Salih, A., Sanchez, O. D., Sanchez-Gila, J., Sanchez-Perez, I., Santarelli, A., Sardovski, Sarenac, D., Sarma, J., Sarno, G., Savonitto, S., Sayied Abdullah, A., Schafer, A., Scherillo, M., Schneider, H., Schuhlen, H., Sciahbasi, A., Seca, L., Sedlon, P., Semenka, J., Serra, L. A., Sesana, M., Sethi, A., Sgueglia, G. A., Shaheen, S., Shahri, H., Sheiban, I., Shyu, K. G., Silva, C. E. F., Sionis, D., Siqueira, D. A., Siqueira, M. J., Smits, P., Sobhy, M., Sokolov, M., Soliman, S., Somani, A. N., Sridhar, G., Stakos, D., Stasek, J., Stefanini, G., Steigen, T. K., Stewart, Stipal, R., Stochino, M. L., Stoel, M. G., Subla, R. M., Suliman, A., Summaria, F., Stoyanov, N., Syed, A. A., Tanaka, Y., Tashani, A., Tauzin, S., Tawade, N., Tawfik, M., Tayeh, O., Terzic, I., Testa, L., Thevan, B., Thiam, M., Tiecco, F., Tierala, I., Tilea, I., Tilsted, H. H., Tomasik, A. R., Tonev, I., Torres Bosco, A., Tousek, P., Townend, J., Tran Ngoc, T., Triantafyllou, K., Tsigkas, G., Tsioufis, C., Turri, M., Tyligadis, G., Ugo, F., Ultramari, F. T., Urban, P., Uren, N., Uretsky, B. F., Uribe, C. E., Usman, B., Valadez Molina, F., Van Houwelingen, K. G., Vandormael, M., Varvarovsky, I., Vassilis, V., Velasquez, D., Verdoia, M., Vermeersch, P., Vidal-Perez, R., Vinesh, J., Violini, R., Vista, J. H., Vogt, F., Vogt, M., Vokac, D., Vom Dahl, J., Vranckx, P., Wahab, A., Wang, R., Wang, T. D., Wani, S., Weisz, S. H., Werner, G. S., Wilkinson, J. R., Wolf, A., Youssef, A., Yumoto, K., Zaderenko, N., Zaghloul Darwish, A. M., Zahn, R., Zaro, T., Zavalloni, D., Zbinden, R., Zekanovic, D., Zhang, B., Zhang, C., Zhang, Y. J., Zhonghan, N., Zingarelli, A., Zueco, J., Zuhairy, H., Abbate, A., Abdel Hamid, M., Abdelmegid, M. A. F., Acuna-Valerio, J., Adriaenssens, T., Agostoni, P., Aikot, H., Alameda, M., Alcaraz, H., Almendro-Delia, M., Altug Cakmak, H., Amir, A., Arjomand, A., Assomull, R., Atalar, E., Avramides, D., Aytek Simsek, M., Aznaouridis, K., Azpeitia, Y., Barnabas, C., Barsness, G. W., Bartorelli, A. L., Basoglu, A., Benezet, J., Benincasa, S., Berland, J., Berrocal, D. H., Bett, N., Boskovic, S., Brandao, V., Caporale, R., Caprotta, F., Carrabba, N., Cazaux, P., Cheniti, G., Chinchilla Calix, H., Chung, W. Y., Cicco, N. A., Cieza, T., Clapp, B., Commeau, P., Cuellar, C., De Benedictis, M., De La Torre Hernandez, J. M., De Vroey, F., Degertekin, M., Eberli, F. R., Eggebrecht, H., Ekicibasi, E., Elmaraghi, M., Elod, P., Ergene, A. O., Fadlalla, V. F., Farah, M. A., Fernandez Vina, R., Ferro, A., Fischer, D., Flore, V., Foley, D. P., Gafoor, S., Gallo, S., Gaspardone, A., Gavrilescu, D., Gentiletti, A., Gilard, M., Giovannelli, F., Gonzalez Pacheco, I., Gonzalo, N., Grajek, S., Gurgel De Medeiros, J. P., Haine, S., Hakim, D., Hakim Vista, J. J., Hallani, H., Hamid, M., Helft, G., Heppell, R. M., Hernandez-Enriquez, M., Hlinomaz, O., Ho Choo, E., Huqi, A., Hurtado, E. O., Iakovou, I., Iosseliani, D., Janssens, L., Jean, M., Jensen, J. K., Jesudason, P., Jimenez Diaz, V. A., Karchevsky, D., Karpovskii, A., Katsimagklis, G., Kereiakes, D., Kersanova, N. C., Kesavan, S., Khaled, H., Khalil, S. A., Kiatchoosakun, S., Kim, K. S., Kirma, C., Koltowski, L., Konteva, M., Kozinski, L., Kuehn, C. R., Kumar, S., Kyriakakis, C. G., Laanmets, P., Labrunie, A., Ladwiniec, A., Lai, G., Laine, M., Latib, A., Lattuca, B., Lazarevic, A. M., Lee, K. S., Legrand, V., Leiva, G., Lester, N., Levchyshyna, O., Livia, G., Londero, H. F., Luha, O., Lupi, A., Lupkovics, G., Maaliki, S., Maeng, M., Mahr, N. C., Mantyla, P., Mariano, E., Marsit, N., Mcdonough, T. J., Medda, M., Mejia Viana, S., Merigo Azpir, C. A., Mitreski, S., Moreno, R., Moreu, J., Muehler, M., Muir, D., Munoz Molina, R., Musilli, N., Myc, J., Nadra, I., Nagy, C. D., Narayanan, A., Neugebauer, P., Nguyen, M., Nick, H., Nicolino, A., Obradovic, S. D., Paizis, I., Panagiotis, P., Park, S. D., Park, S. J., Pasquetto, G., Patel, D., Paunovic, D., Pedon, L., Pereira Machado, F., Pershukov, H., Petrou, E., Pinton, F. A., Preti, G., Puri, R., Pyxaras, S. A., Quintanilla, J., Rhouati, A., Ribeiro De Oliveira, I., Rivetti, L., Rodriguez, A. E., Rotevatn, S., Rubartelli, P., Sachdeva, R., Sanchez-Perez, H., Sangiorgi, G., Santoro, G. M., Saporito, F., Scappaticci, M., Schmermund, A., Schmidt, J. E., Schmitz, T., Schneider, T. I., Schuchlenz, H., Sepulveda Varela, P., Shaw, E., Silva Marques, J., Skalidis, E., Slhessarenko, J., Spaulding, C., Stankovic, G., Suwannasom, P., Synetos, A., Szuster, E., Taha, S., Tavano, D., Tebet, M., Thury, A., Toutouzas, K., Triantafyllis, A. S., Tsikaderis, D., Tumscitz, C., Tzanogiorgis, I., Udovichenko, A., Ulrike, N., Unikas, R., Valerio, M. G., Van Mieghem, C., Vandendriessche, T., Vavlukis, M., Vigna, C., Vilar, J. V., Vizzari, G., Voudris, V., Wafa, S., Wagner, D. R., Wichter, T., Wiedemann, S., Williams, P. D., Woody, W., Yding, A., Zachow, G., and Webster, M.

Subjects
Male, medicine.medical_specialty, Time Factors, Percutaneous, Time Factor, Psychological intervention, Alternative medicine, MEDLINE, Practice Patterns, Drug Administration Schedule, acute coronary syndrome, Settore MED/11, Percutaneous Coronary Intervention, Pharmacotherapy, Drug Therapy, Physicians, Surveys and Questionnaires, drug-eluting stent, Humans, Surveys and Questionnaire, Medicine, Practice Patterns, Physicians', health care economics and organizations, clopidogrel, dual antiplatelet therapy (DAPT), stable coronary artery disease, Drug Therapy, Combination, Evidence-Based Medicine, Health Care Surveys, Platelet Aggregation Inhibitors, Practice Guidelines as Topic, Practice Patterns, Physicians, Treatment Outcome, Stents, business.industry, Platelet Aggregation Inhibitor, Coronary stenting, Evidence-based medicine, Middle Aged, Surgery, Clinical trial, Health Care Survey, Combination, Emergency medicine, Female, Cardiology and Cardiovascular Medicine, business, Human
Abstract

AIMS Our aim was to report on a survey initiated by the European Association of Percutaneous Cardiovascular Interventions (EAPCI) concerning opinion on the evidence relating to dual antiplatelet therapy (DAPT) duration after coronary stenting. METHODS AND RESULTS Results from three randomised clinical trials were scheduled to be presented at the American Heart Association Scientific Sessions 2014 (AHA 2014). A web-based survey was distributed to all individuals registered in the EuroIntervention mailing list (n=15,200) both before and after AHA 2014. A total of 1,134 physicians responded to the first (i.e., before AHA 2014) and 542 to the second (i.e., after AHA 2014) survey. The majority of respondents interpreted trial results consistent with a substantial equipoise regarding the benefits and risks of an extended versus a standard DAPT strategy. Two respondents out of ten believed extended DAPT should be implemented in selected patients. After AHA 2014, 46.1% of participants expressed uncertainty about the available evidence on DAPT duration, and 40.0% the need for clinical guidance. CONCLUSIONS This EAPCI survey highlights considerable uncertainty within the medical community with regard to the optimal duration of DAPT after coronary stenting in the light of recent reported trial results. Updated recommendations for practising physicians to guide treatment decisions in routine clinical practice should be provided by international societies.

Published
2015

109. Characterization of the terminal column of TRIGA Mark II reactor of Mainz through of alanine pellets

Author

GALLO, Salvatore, Schmitz T, BARTOLOTTA, Antonio, COLLURA, Giorgio, Hampel G, PANZECA, Salvatore, MARRALE, Maurizio, Gallo S, Schmitz T, Bartolotta A, Collura G, Hampel G, Panzeca S, and Marrale M

Subjects
Settore FIS/01 - Fisica Sperimentale, MC simulation, Alanine, ESR, EPR, Neutron, Fluka, Settore FIS/07 - Fisica Applicata(Beni Culturali, Ambientali, Biol.e Medicin)
Abstract

We have studied the ESR response of alanine pellets with and without gadolinium exposed to the thermal column of the TRIGA Mark II research reactor at the University of Mainz (Germany). The choice of Gd as additive nucleus is due to its very high capture cross section to thermal neutrons and to the possibility for secondary particles produced after interaction with thermal neutrons of releasing their energy in the neighborhood of the reaction site. In particular, it was found that low concentration (5% by weight) of Gd brings about a neutron sensitivity enhancement of more than 10 times without heavily reducing tissue equivalence. Monte Carlo (MC) simulations of both response of alanine and Gd-alanine pellets with FLUKA code were performed and the results were compared with the experimental values.

Published
2017

111. Modalités de l’accouchement dans la prévention de la dystocie des épaules en cas de facteurs de risque identifiés

Author

Schmitz T

Subjects
Gynecology, medicine.medical_specialty, Reproductive Medicine, business.industry, medicine, Obstetrics and Gynecology, General Medicine, Ultrasonography, Induction of labor, business, Infant newborn
Abstract

Resume But Determiner l’impact de la realisation (i) d’une confrontation fœto-pelvienne pour l’aide au choix de la voie d’accouchement, (ii) d’une cesarienne, (iii) d’un declenchement du travail et (iv) de certaines modalites de prise en charge de l’accouchement sur le risque de survenue d’une dystocie des epaules chez les patientes enceintes d’un fœtus macrosome, en association ou non a un diabete maternel, et chez celles aux antecedents de dystocie des epaules. Materiel et methodes Consultation de la base de donnees Medline, de la Cochrane Library et des recommandations des societes savantes francaises et etrangeres. Resultats En cas de suspicion clinique de macrosomie fœtale, la realisation d’une echographie est encouragee afin de preciser la suspicion de macrosomie et finalement d’aider aux prises de decisions (accord professionnel). En raison d’un nombre de faux positifs eleve et d’une augmentation du nombre de cesariennes associees a son utilisation, il n’est pas recommande de realiser une radiopelvimetrie pour prevenir la dystocie des epaules en cas de suspicion de macrosomie fœtale (accord professionnel). Afin d’eviter les complications de la dystocie des epaules et en particulier les lesions irreversibles du plexus brachial, il est recommande de pratiquer une cesarienne en cas d’estimation de poids fœtal superieure a 4500 g en cas de diabete associe (grade C) et superieure a 5000 g en l’absence de diabete (grade C). Les donnees publiees ne fournissent pas d’arguments formels pour recommander un declenchement du travail systematique en cas de suspicion de macrosomie fœtale (accord professionnel). Neanmoins, un declenchement du travail sera d’autant plus a privilegier que les conditions locales seront favorables et le terme proche de 39 SA (accord professionnel). En cas de conditions locales favorables et a partir de 39 SA, un declenchement du travail est encourage (accord professionnel). Faute de donnees publiees, il n’est pas possible d’emettre de recommandations quant au declenchement du travail en cas de diabete maternel et de macrosomie fœtale. Il n’est pas recommande de realiser une manœuvre de McRoberts prophylactique en cas de suspicion de macrosomie fœtale pour prevenir la survenue d’une dystocie des epaules (grade C). Faute de donnees publiees, il n’est pas possible d’emettre de recommandations concernant la realisation d’une episiotomie ou d’une manœuvre de restitution pour prevenir la dystocie des epaules en cas de suspicion de macrosomie fœtale. En cas de non-progression et de suspicion de macrosomie fœtale, la realisation d’une cesarienne est a preferer a une extraction instrumentale en cas de presentation non engagee ou engagee partie haute (grade C) ; la realisation d’une extraction instrumentale est a preferer a une cesarienne en cas de presentation engagee partie moyenne ou partie basse (grade C). En cas d’antecedent de dystocie des epaules associee a des complications neonatales ou maternelles severes, une cesarienne pourra etre envisagee a la grossesse suivante (accord professionnel). Conclusion Deux mesures sont recommandees pour prevenir la survenue d’une dystocie des epaules et les complications qui y sont associees, le declenchement du travail et la cesarienne. Un declenchement du travail sera d’autant plus a privilegier que les conditions locales seront favorables et le terme proche de 39 SA (accord professionnel). En cas de conditions locales favorables et a partir de 39 SA, un declenchement du travail est encourage (accord professionnel). Une cesarienne devrait etre realisee avant travail en cas (i) d’estimation de poids fœtal superieure a 4500 g chez la patiente diabetique (grade C), (ii) d’estimation de poids fœtal superieure a 5000 g chez la patiente non diabetique (grade C) et (iii) pendant le travail, en cas de suspicion de macrosomie et de non-progression lorsque la presentation n’est pas engagee ou engagee seulement partie haute (grade C). En cas d’antecedent de dystocie des epaules associee a des complications neonatales ou maternelles severes, une cesarienne pourra etre envisagee a la grossesse suivante (accord professionnel).

Published
2015

112. Surgery for spinal meningiomas: Risks and potential of geriatric patients

Author

Schwake, M, Adeli, A, Sporns, P, Ewelt, C, Schmitz, T, Sicking, J, Heß, K, Paulus, W, Stummer, W, and Brokinkel, B

Subjects
ddc: 610, 610 Medical sciences, Medicine
Abstract

Objective: The majority of surgeries for spinal meningiomas are performed in geriatric patients with commonly poor neurological and medical condition. However, age-related analyses of preoperative symptoms and functional outcomes are rare. Methods: Clinical, neuropathological and radiological data[for full text, please go to the a.m. URL], 69. Jahrestagung der Deutschen Gesellschaft für Neurochirurgie (DGNC), Joint Meeting mit der Mexikanischen und Kolumbianischen Gesellschaft für Neurochirurgie

Published
2018
Full Text
View/download PDF

115. Session 9: Biomaterials -Elektrospinning

Author

Weigel, T., primary, Schmitz, T., additional, Jannasch, M., additional, Schürlein, S., additional, Al Hijailan, R., additional, Suliman, S., additional, Walles, H., additional, and Hansmann, J., additional

Published
2019
Full Text
View/download PDF

117. Rupture prématurée des membranes avant terme : recommandations pour la pratique clinique du CNGOF — Texte court

Author

Schmitz, T., primary, Sentilhes, L., additional, Lorthe, E., additional, Gallot, D., additional, Madar, H., additional, Doret-Dion, M., additional, Beucher, G., additional, Charlier, C., additional, Cazanave, C., additional, Delorme, P., additional, Garabedian, C., additional, Azria, É., additional, Tessier, V., additional, Senat, M.-V., additional, and Kayem, G., additional

Published
2018
Full Text
View/download PDF

120. The risk of venous thromboembolism in ENT and head & neck surgery

Author

Rivera Schmitz T, Ossa Echeverri Cc, Osorio Velasquez A, Santidrian Hidalgo C, Betances Reinoso Fa, and Chiesa Estomba C

Subjects
Adult, Male, medicine.medical_specialty, Otorhinolaryngologic Surgical Procedures, Deep vein, Postoperative Complications, Risk Factors, Thromboembolism, medicine, Humans, Child, Retrospective Studies, Venous Thrombosis, business.industry, Incidence, Head and neck cancer, Retrospective cohort study, medicine.disease, Thrombosis, Surgery, Pulmonary embolism, Venous thrombosis, medicine.anatomical_structure, Otorhinolaryngology, Female, Pulmonary Embolism, business
Abstract

Objectives Venous thromboembolic disease (VTD) includes deep vein thrombosis (DVT) and pulmonary embolism (PE), thus is one of the most feared postoperative complications developed by patients at any surgical department, because of high morbidity and mortality associated with it. Materials and methods We performed a retrospective study including all patients operated on at the Otolaryngology Head and Neck Department (tertiary hospital) between January 2009 and December 2013. Results A total of 9007 surgical procedures were performed, including 7150 elective surgeries under general anesthesia, with 2127 on children and 5023 on adults. A total of 1989 patients had oncological head and neck surgery, eight cases had VTE complications, which represents 0.08% of patients. All of those complicated cases had head and neck cancer (8/1989 = 0.4%) and belonged to the group of scheduled surgeries under general anesthesia (8/7150 = 0.1%). Conclusion The incidence of DVT and PE in ENT and head and neck surgery appears to be lower than in other surgical specialties. Oncological surgery of the head and neck, usually associated with other risk factors, appears to increase the risk of VTD.

Published
2015

121. Perinatal outcome after planned vaginal delivery in monochorionic compared with dichorionic twin pregnancy.

Author

Schmitz, T., Korb, D., Azria, E., Garabédian, C., Rozenberg, P., Sénat, M. V., Sentilhes, L., Vayssière, C., Winer, N., and Goffinet, F.

Subjects
*FETOFETAL transfusion, *PREGNANCY outcomes, *PREGNANCY, *BIRTH order, *REPRODUCTIVE technology, *TWINS
Abstract

Objective: To assess, according to chorionicity, the perinatal outcome of twin pregnancy in which vaginal delivery is planned. Methods: JUMODA (JUmeaux MODe d'Accouchement) was a national prospective population‐based cohort study of twin pregnancies, delivered in 176 maternity units in France, from February 2014 to March 2015. In this planned secondary analysis, we assessed, according to chorionicity, the perinatal outcome of twin pregnancies, in which vaginal delivery was planned, that delivered at or after 32 weeks of gestation with the first twin in cephalic presentation. In order to select a population with well‐recognized indications for planned vaginal delivery, we applied the same exclusion criteria as those in the Twin Birth Study, an international randomized trial. Monochorionic twin pregnancies with twin‐to‐twin transfusion syndrome or twin anemia–polycythemia sequence were defined as complicated and were excluded. The primary outcome was a composite of intrapartum mortality and neonatal morbidity and mortality. Multivariable logistic regression models were used to control for potential confounders. Subgroup analyses were conducted according to birth order (first or second twin) and gestational age at delivery (< 37 or ≥ 37 weeks of gestation). Results: Among 3873 twin pregnancies, in which vaginal delivery was planned, that delivered at ≥ 32 weeks' gestation with the first twin in cephalic presentation, meeting the inclusion criteria of the Twin Birth Study, 729 (18.8%) were uncomplicated monochorionic twin pregnancies and 3144 (81.2%) were dichorionic twin pregnancies. The rate of composite intrapartum mortality and neonatal morbidity and mortality did not differ between uncomplicated monochorionic (27/1458 (1.9%)) and dichorionic (107/6288 (1.7%)) twin pregnancies when adjusting for conception by assisted reproductive technologies (adjusted relative risk, 1.07 (95% CI, 0.66–1.75)). No significant difference in the primary outcome was found between the groups on subgroup analyses according to birth order and gestational age at delivery. Conclusion: When vaginal delivery is planned, and delivery occurs at ≥ 32 weeks of gestation with the first twin in cephalic presentation, uncomplicated monochorionic twin pregnancy is not associated with a higher rate of composite intrapartum mortality and neonatal morbidity and mortality compared with dichorionic twin pregnancy. © 2020 International Society of Ultrasound in Obstetrics and Gynecology A video abstract of this article is available online here. [ABSTRACT FROM AUTHOR]

Published
2021
Full Text
View/download PDF

124. Characterization of aerosol plumes in nanosecond laser ablation of molecular solids at atmospheric pressure

Author

Schmitz, T., Koch, J., Günther, D., Zenobi, R., Schmitz, T., Koch, J., Günther, D., and Zenobi, R.

Abstract

Ablation of molecular solids with pulsed ultraviolet lasers at atmospheric pressure is an important process in (bio-)organic mass spectrometry. Of practical importance for analytical sampling and analysis are the plume formation and expansion. Plumes formed by atmospheric-pressure laser ablation of anthracene and 2,5-dihydroxybenzoic acid (2,5-DHB) were studied by light scattering imaging, which showed significant material release in the form of aerosols. The monitored plume expansion dynamics could be fitted to the drag-force model, yielding initial plume velocities of 150m/s for anthracene and 43m/s for DHB. While the angle of incidence does not affect the plume direction and propagation, a large dependence of the plume-expansion velocity on the laser pulse energy could be found, which is limited at atmospheric pressure by the onset of plasma shielding. With respect to analytical applications, the efficiency of sampling of the laser ablation products by a capillary could be experimentally visualized

Published
2018

125. EPR ANALYSIS OF ALANINE WITH GADOLINIUM FOR DOSIMETRY AT TRIGA MARK II REACTOR OF MAINZ

Author

GALLO, Salvatore, MARRALE, Maurizio, Schmitz, T, Hampel, G, LONGO, Anna, PANZECA, Salvatore, TRANCHINA, Luigi, Gallo, S, Marrale, M, Schmitz, T, Hampel, G, Longo, A, Panzeca, S, and Tranchina, L

Subjects
Settore ING-IND/20 - Misure E Strumentazione Nucleari, Settore ING-IND/18 - Fisica Dei Reattori Nucleari, Settore FIS/01 - Fisica Sperimentale, MAINZ REACTOR, DOSIMETRY, ALANINE, ESR, EPR, FLUKA, NCT, GADOLINIUM, Settore FIS/07 - Fisica Applicata(Beni Culturali, Ambientali, Biol.e Medicin)
Abstract

Negli ultimi anni il crescente interesse verso la radioterapia a cattura neutronica (internazionalmente nota come Neutron Capture Therapy - NCT) per il trattamento di neoplasie ha stimolato diverse attività di ricerca finalizzate alla caratterizzazione del fascio utilizzato e all'ottimizzazione delle procedure radioterapiche. La corretta riuscita del trattamento NCT e il monitoraggio della dose impartita non possono prescindere dalla valutazione delle varie componenti del fascio impiegato (neutronica e fotonica). Infatti, durante le procedure di moderazione dei neutroni, si verifica la produzione di fotoni e la stima dei rischi a cui sono soggetti i tessuti sani sottoposti al campo misto necessita precise ed accurate misure della componente fotonica. Tra i vari sistemi dosimetrici trovano largo impiego i rivelatori a stato solido EPR (Risonanza Paramagnetica Elettronico) a base di alanina che presentano diversi vantaggi come la tessuto equivalenza per fasci di fotoni, la linearità della risposta in un ampio intervallo di dose, l'elevata stabilità dei radicali liberi radioindotti, la non distruttività della lettura del dosimetro e il basso costo dei dosimetri. Queste caratteristiche, se associate alla possibilità di riconoscere le varie componenti di un campo misto di radiazione, renderebbero l'alanina un ottimo candidato per le dosimetria in campi di neutroni-gamma. In questo lavoro abbiamo studiato la risposta di dosimetri di alanina con e senza gadolinio (Gd) irradiati nella colonna termica del reattore di ricerca di Mainz. I dosimetri di alanina semplice utilizzati sono stati prodotti da SynergyHealth (Germania), mentre i dosimetri con aggiunta di Gd sono stati prodotti presso l'Università di Palermo. Le irradiazioni sono state effettuate all'interno di contenitori di polietilene per garantire le condizioni di equilibrio di particelle cariche. Le misure EPR sono state effettuate mediante spettrometro Bruker ECS106 dotato di una cavità TE102 rettangolare. I risultati degli esperimenti EPR sono stati confrontati con le simulazioni Monte Carlo finalizzate ad ottenere informazioni sul contributo delle varie componenti (neutronica e fotonica) alla dose totale misurata mediante dosimetri EPR.

Published
2015

126. Comparison of EPR response of pure alanine and alanine with gadolinium dosimeters exposed to TRIGA Mainz reactor

Author

Panzeca, S., Marrale, M., Schmitz, T., Gallo, S., Hampel, G., Longo, A., Tranchina, L., Brai, M., PANZECA, S, MARRALE, M, SCHMITZ, T, GALLO, S, HAMPEL, G, LONGO, A, TRANCHINA, L, and BRAI, M

Subjects
Gadolinium, ESR, EPR, Alanine, FLUKA, Settore ING-IND/18 - Fisica Dei Reattori Nucleari, Settore FIS/01 - Fisica Sperimentale, Settore FIS/07 - Fisica Applicata(Beni Culturali, Ambientali, Biol.e Medicin)
Abstract

The development of Neutron Capture Therapy (NCT) for cancer treatments has stimulated the research for beam characterization in order to optimize the therapy procedures. The NCT has found to be promising for treatments of tumours which hardly can be treated with other techniques, such as gliomas. Alongside with the improvements of this technique, the development of procedures for the beam characterization arouses great interest in order to optimize the therapy protocol by reliably determining the various (neutronic and photonic) components of the mixed beam usually employed for therapy. Electron Paramagnetic Resonance (EPR) dosimetry for electron and photon beams with alanine has attracted the attention of many research groups for dosimetric purposes. Furthermore, the applications of EPR dosimetry for high LET radiation beams, such as carbon ions and neutrons, are continuously increasing. This is because of the very good dosimetric features of alanine EPR detectors such as: tissue equivalence for photon beams, linearity of its dose-response over a wide range, high stability of radiation induced free radicals, no destructive read-out procedure, no need of sample treatment before EPR signal measurement and low cost of the dosimeters. Moreover, in order to improve the sensitivity to thermal neutrons of alanine dosimeters the addition of nuclei such as gadolinium oxidewas previously studied. The choice of Gd as additive nucleus is due to its very high capture cross section to thermal neutrons and to the possibility for secondary particles produced after interaction with thermal neutrons of releasing their energy in the neighbourhood of the reaction site. In particular, it was found that low concentration (i.e. 5% by weight) of gadolinium oxide brings about an neutron sensitivity enhancement of more than 10 times without heavily reducing tissue equivalence. We have studied the response of alanine pellets with and without gadolinium exposed to the thermal column of the TRIGA Mark II research reactor at the University of Mainz. Pure alanine dosimeters used were produced by Synergy Health (Germany) whereas the Gd-added dosimeters were produced at the University of Palermo. The irradiations were performed inside polyethylene holders to guarantee charged particles equilibrium conditions. The results of EPR experiments are compared to Monte Carlo (MC) simulations aimed at obtaining information about the contribution of the various components to the total dose measured by means of EPR dosimeters. For alanine dosimeters a good agreement between experimental data and MC simulation have been achieved.

Published
2015

127. Investigation of alanine with gadolinium for ESR dosimetry at TRIGA Mark II reactor of Mainz

Author

MARRALE, Maurizio, SCHMITZ, T, GALLO, Salvatore, PANZECA, Salvatore, HAMPEL, G, LONGO, Anna, PANZECA, S, TRANCHINA, Luigi, MARRALE, M, SCHMITZ, T, GALLO, S, PANZECA, S, HAMPEL, G, LONGO, A, and TRANCHINA, L

Subjects
FLUKA, Settore ING-IND/18 - Fisica Dei Reattori Nucleari, Settore FIS/01 - Fisica Sperimentale, NCT, Gadolinium, ESR, Settore FIS/07 - Fisica Applicata(Beni Culturali, Ambientali, Biol.e Medicin)
Abstract

In this work we have studied the response of alanine pellets with and without gadolinium exposed to the thermal column of the TRIGA Mark II research reactor at the University of Mainz

Published
2015

133. Neonatal Outcomes for Women at Risk of Preterm Delivery Given Half Dose Versus Full Dose of Antenatal Betamethasone: A Randomized, Multicenter, Double-blind, Placebo-controlled, Noninferiority Trial.

Author

Schmitz, T., Doret-Dion, M., Sentilhes, L., Parant, O., Claris, O., Renesme, L., Abbal, J., Girault, A., Torchin, H., Houllier, M., Le Saché, N., Vivanti, A.J., De Luca, D., Winer, N., Flamant, C., Thuillier, C., Boileau, P., Blanc, J., Brevaut, V., and Bouet, P.E.

Published
2023
Full Text
View/download PDF

135. The spectrum of care for pediatric refugees and asylum seekers at a tertiary health care facility in Switzerland in 2015.

Author

Pohl, C, Mack, I, Schmitz, T, Ritz, N, Pohl, C, Mack, I, Schmitz, T, and Ritz, N

Abstract

UNLABELLED: The aim of this retrospective study was to describe the epidemiology and spectrum of infections of admitted pediatric refugees and asylum seekers in a tertiary referral hospital in a high-income country in Europe. We identified recent refugees and asylum seekers < 18 years of age admitted to the University Children's Hospital in Basel, Switzerland, in 2015. A retrospective analysis was performed using electronic patient records. We identified 105 admissions in 93 patients with a median age of 5.7 (IQR 2.6-14.5) years. Eritrea, Syria, and Afghanistan were the most frequent countries of origin. The median duration of admission was 4 (IQR 2-6) days with infections and elective surgical interventions being the most common reason (54.8 and 16.1%, respectively). Most infections were airway, skin, and gastrointestinal in 46.4, 20.2, and 11.9%, respectively. The prevalence of tropical infections was 11.9%. The main pathogens identified were influenza A virus (13.8%), Staphylococcus aureus (10.3%), and rhino/enterovirus (10.3%). Previous medical non-infectious conditions were recorded in 13%. CONCLUSION: The study revealed a high burden of infections in admitted patients mostly caused by well-known pathogens prevalent also in the local population. Both tropical infections and pre-existing non-infectious conditions are also important in admitted patients. Better epidemiological data is required to optimize health care for this medically most vulnerable population in refugee crises. What is Known: • Pediatric refugees and asylum seekers are the most vulnerable population in refugee crises. • Data on health concerns and needs in this population is scarce. What is New: • This is one of the first studies on the epidemiology of pediatric refugees and asylum seekers treated as inpatients in a European high-income country. • The high burden of infections is mostly caused by well-known pathogens prevalent also in the local population.

Published
2017

137. Dosimetry of Mainz reactors by means of ESR dosimetry with alanine added with gadolinium

Author

MARRALE, Maurizio, BRAI, Maria, LONGO, Anna, PANZECA, Salvatore, GALLO, Salvatore, TRANCHINA, Luigi, Schmitz, T, Hampel, G, Marrale, M, Schmitz, T, Hampel, G, Brai, M, Longo,A, Panzeca, S, Gallo, S, and Tranchina, L

Subjects
Settore ING-IND/20 - Misure E Strumentazione Nucleari, ESR dosimetry, Alanine, Gadolinium, NCT, Settore FIS/01 - Fisica Sperimentale, Settore FIS/07 - Fisica Applicata(Beni Culturali, Ambientali, Biol.e Medicin)
Published
2014

140. Recommandations pour la pratique clinique : prévention de la prématurité spontanée et de ses conséquences (hors rupture des membranes) — Texte des recommandations (texte court)

Author

Sentilhes, L., primary, Sénat, M.-V., additional, Ancel, P.-Y., additional, Azria, E., additional, Benoist, G., additional, Blanc, J., additional, Brabant, G., additional, Bretelle, F., additional, Brun, S., additional, Doret, M., additional, Ducroux-Schouwey, C., additional, Evrard, A., additional, Kayem, G., additional, Maisonneuve, E., additional, Marcellin, L., additional, Marret, S., additional, Mottet, N., additional, Paysant, S., additional, Riethmuller, D., additional, Rozenberg, P., additional, Schmitz, T., additional, Torchin, H., additional, and Langer, B., additional

Published
2016
Full Text
View/download PDF

143. The alanine detector in BNCT dosimetry:Dose response in thermal and epithermal neutron fields

Author

Schmitz, T., Bassler, Niels, Blaickner, M., Ziegner, M., Hsiao, M. C., Liu, Y. H., Koivonoro, H., Auterinen, I., Serén, T., Kotiluoto, P., Palmans, Hugo, Sharpe, Peter, Langguth, P., and Hampel, G.

Subjects
dosimetry, mixed fields, Physics::Medical Physics, technology, industry, and agriculture, neutrons, Monte Carlo modeling, alanine
Abstract

Purpose: The response of alanine solid state dosimeters to ionizing radiation strongly depends on particle type and energy. Due to nuclear interactions, neutron fields usually also consist of secondary particles such as photons and protons of diverse energies. Various experiments have been carried out in three different neutron beams to explore the alanine dose response behavior and to validate model predictions. Additionally, application in medical neutron fields for boron neutron capture therapy is discussed. Methods: Alanine detectors have been irradiated in the thermal neutron field of the research reactor TRIGA Mainz, Germany, in five experimental conditions, generating different secondary particle spectra. Further irradiations have been made in the epithermal neutron beams at the research reactors FiR 1 in Helsinki, Finland, and Tsing Hua open pool reactor in HsinChu, Taiwan ROC. Readout has been performed with electron spin resonance spectrometry with reference to an absorbed dose standard in a 60Co gamma ray beam. Absorbed doses and dose components have been calculated using the Monte Carlo codes FLUCK and MCNP . The relative effectiveness (RE), linking absorbed dose and detector response, has been calculated using the Hansen Olsen alanine response model. Results: The measured dose response of the alanine detector in the different experiments has been evaluated and compared to model predictions. Therefore, a relative effectiveness has been calculated for each dose component, accounting for its dependence on particle type and energy. Agreement within 5% between model and measurement has been achieved for most irradiated detectors. Significant differences have been observed in response behavior between thermal and epithermal neutron fields, especially regarding dose composition and depth dose curves. The calculated dose components could be verified with the experimental results in the different primary and secondary particle fields. Conclusions: The alanine detector can be used without difficulty in neutron fields. The response has been understood with the model used which includes the relative effectiveness. Results and the corresponding discussion lead to the conclusion that application in neutron fields for medical purpose is limited by its sensitivity but that it is a useful tool as supplement to other detectors and verification of neutron source descriptions.

Published
2015

144. Endothelial Caveolin-1 regulates the radiation response of epithelial prostate tumors

Author

Klein, Diana, Schmitz, T., Verhelst, V., Panic, Andrej, Schenck, Marcus, Reis, Henning, Drab, Marek, Sak, Ali, Herskind, Carsten, Maier, Patrick J., and Jendrossek, Verena

Subjects
Medizin
Abstract

The membrane protein caveolin-1 (Cav1) recently emerged as a novel oncogene involved in prostate cancer progression with opposed regulation in epithelial tumor cells and the tumor stroma. Here we examined the role of stromal Cav1 for growth and radiation response of MPR31-4 prostate cancer xenograft tumors using Cav1-deficient C57Bl/6 mice. Syngeneic MPR31-4 tumors grew faster when implanted into Cav1-deficient mice. Increased tumor growth on Cav1-deficient mice was linked to decreased integration of smooth muscle cells into the wall of newly formed blood vessels and thus with a less stabilized vessel phenotype compared with tumors from Cav1 wild-type animals. However, tumor growth delay of MPR31-4 tumors grown on Cav1 knockout mice to a single high-dose irradiation with 20 Gray was more pronounced compared with tumors grown on wild-type mice. Increased radiation-induced tumor growth delay in Cav1-deficient mice was associated with an increased endothelial cell apoptosis. In vitro studies using cultured endothelial cells (ECs) confirmed that the loss of Cav1 expression increases sensitivity of ECs to radiation-induced apoptosis and reduces their clonogenic survival after irradiation. Immunohistochemical analysis of human tissue specimen further revealed that although Cav1 expression is mostly reduced in the tumor stroma of advanced and metastatic prostate cancer, the vascular compartment still expresses high levels of Cav1. In conclusion, the radiation response of MPR31-4 prostate tumors is critically regulated by Cav1 expression in the tumor vasculature. Thus, Cav1 might be a promising therapeutic target for combinatorial therapies to counteract radiation resistance of prostate cancer at the level of the tumor vasculature. OA Förderung 2015

Published
2015

145. Probabilistic Sequential Prediction of Cutting Force Using Kienzle Model in Orthogonal Turning Process.

Author

Salehi, M., Schmitz, T. L., Copenhaver, R., Haas, R., and Ovtcharova, J.

Subjects
*CUTTING force, *MARKOV chain Monte Carlo, *PROBABILITY theory
Abstract

Probabilistic sequential prediction of cutting forces is performed applying Bayesian inference to Kienzle force model. The model uncertainties are quantified using the Metropolis algorithm of the Markov chain Monte Carlo (MCMC) approach. Prior probabilities are established and posteriors of the models parameters and force predictions are completed using the results of orthogonal turning experiments. Two types of tools with chamfer (rake) angles of 0 deg and -10 deg are tested under various cutting speed and feed per revolution values. First, Bayesian inference is applied to two force models, Merchant and Kienzle, to investigate the cutting force prediction at the low feed values for the 0 deg rake angle tool. Second, the results of the posteriors of the Kienzle model parameters are used as prior probabilities of the -10 deg rake angle tool. The simulation results of the 0 deg and -10 deg tool rake angle are compared with the experiments which are obtained under other cutting conditions for model verification. Maximum prediction errors of 7% and 9% are reported for the tangential and feed forces, respectively. This indicates a good capability of the Bayesian inference for model parameter identification and cutting force prediction considering the inherent uncertainty and minimum input experimental data. [ABSTRACT FROM AUTHOR]

Published
2019
Full Text
View/download PDF

146. Reference values for biochemical tests during pregnancy: analysis of the PRECAREbio Cohort and correlation with precarious status

Author

Phelippeau, J, Azria, E, Ceccaldi, PF, Carine, Khater, Koskas, M, Mandelbrot, L, Estellat, Candice, Muller, F, Schmitz, T, and Luton, D

Abstract

To establish normal current values of various biochemical parameters during pregnancy in the northern area of Paris (France) in a subgroup from the PreCARE cohort and to study their changes according to the term of pregnancy, and to determine the influence of maternal precarity.

Published
2024
Full Text
View/download PDF

147. Quantification of external uncertainties in the design process of production networks

Author

Schuh, G., Prote, J. -P, Schmitz, T., Nett, S., Schuh, G., Prote, J. -P, Schmitz, T., and Nett, S.

Abstract

Decisions regarding the design of production networks are a significant challenge for companies. Possible network alternatives have to be evaluated for future points of time for which uncertainties about external factors such as price and wage changes occur. Therefore, this paper presents a quantitative approach for uncertainty assessment. Possible developments of external factors are used to create consistent scenarios which are then integr © 2016, Carl Hanser Verlag. All rights reserved., Export Date: 24 October 2017; Article; CODEN: ZZWFF. QC 20171205

Published
2016
Full Text
View/download PDF

148. Imperatives and politeness in Dutch

Author

Hoop, H. de, Klatter-Folmer, H.A.K., Mulder, G.J., Schmitz, T., Hoop, H. de, Klatter-Folmer, H.A.K., Mulder, G.J., and Schmitz, T.

Abstract

06 februari 2016, Contains fulltext : 160506.pdf (Publisher’s version ) (Open Access)

Published
2016

149. Fractional flow reserve in the diagnostics of coronary artery disease. Clinical importance, performance and interpretation

Author

Moellmann, H., Rudolph, T., Rieber, J., Eggebrecht, H., Richardt, G., Schmitz, T., Werner, N., Achenbach, S., Moellmann, H., Rudolph, T., Rieber, J., Eggebrecht, H., Richardt, G., Schmitz, T., Werner, N., and Achenbach, S.

Abstract

Invasive measurement of the fractional flow reserve (FFR) allows determination of the hemodynamic relevance of a given coronary artery stenosis. Several clinical trials could demonstrate the superiority of FFR-based decision-making for or against percutaneous coronary intervention (PCI) in comparison to visual quantification of the severity of a stenosis. These results led to measurement of the FFR being included in the current guideline recommendations on myocardial revascularization. This article elaborates the theoretical background of measurement of the FFR, summarizes the decisive clinical data and provides comprehensive practical instructions for the safe and rapid measurement of FFR in routine clinical practice.

Published
2016

Catalog

Books, media, physical & digital resources
See catalog results